Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system. The company's platform and therapies specialize in the research and development of small and large molecule therapeutics across the blood-brain barrier, enabling clients to have rapidly advance therapies to treat the patients and provide meaningful medical improvement in their lives.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2022 | Series A | $47M | 4 | Westlake Village BioPartners | — | Detail |
Apr 26, 2021 | Funding Round | — | 2 | Corner Ventures Westlake Village BioPartners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Westlake Village BioPartners | Yes | Series A |
Alexandria Venture Investments | — | Series A |
Caltech | — | Series A |
Corner Ventures | — | Series A |